Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS)
CNY 8.29
(-0.72%)
CNY 8.29
(-0.72%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 5.51 Billion CNY | 4.09% |
| 2022 | 5.3 Billion CNY | 8.31% |
| 2021 | 4.89 Billion CNY | 11.1% |
| 2020 | 4.4 Billion CNY | 26.44% |
| 2019 | 3.48 Billion CNY | 13.63% |
| 2018 | 3.06 Billion CNY | 52.32% |
| 2017 | 2.01 Billion CNY | 6.33% |
| 2016 | 1.89 Billion CNY | 28.09% |
| 2015 | 1.47 Billion CNY | 28.5% |
| 2014 | 1.15 Billion CNY | 14.03% |
| 2013 | 1 Billion CNY | 22.23% |
| 2012 | 825.37 Million CNY | 13.99% |
| 2011 | 724.07 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 5.87 Billion CNY | -4.7% |
| 2024 Q1 | 5.35 Billion CNY | -3.03% |
| 2024 Q2 | 6.16 Billion CNY | 15.21% |
| 2023 FY | 5.51 Billion CNY | 4.09% |
| 2023 Q2 | 5.45 Billion CNY | -1.24% |
| 2023 Q3 | 5.7 Billion CNY | 4.51% |
| 2023 Q4 | 5.51 Billion CNY | -3.19% |
| 2023 Q1 | 5.52 Billion CNY | 4.17% |
| 2022 Q1 | 5.15 Billion CNY | 5.21% |
| 2022 Q2 | 5.15 Billion CNY | 0.11% |
| 2022 Q4 | 5.3 Billion CNY | -0.16% |
| 2022 Q3 | 5.31 Billion CNY | 2.99% |
| 2022 FY | 5.3 Billion CNY | 8.31% |
| 2021 FY | 4.89 Billion CNY | 11.1% |
| 2021 Q1 | 4.31 Billion CNY | -2.07% |
| 2021 Q2 | 4.34 Billion CNY | 0.8% |
| 2021 Q3 | 4.56 Billion CNY | 5.05% |
| 2021 Q4 | 4.89 Billion CNY | 7.13% |
| 2020 Q1 | 3.56 Billion CNY | 2.39% |
| 2020 FY | 4.4 Billion CNY | 26.44% |
| 2020 Q2 | 3.78 Billion CNY | 6.03% |
| 2020 Q4 | 4.4 Billion CNY | 2.06% |
| 2020 Q3 | 4.31 Billion CNY | 14.12% |
| 2019 Q2 | 3.25 Billion CNY | 0.99% |
| 2019 Q1 | 3.22 Billion CNY | 5.23% |
| 2019 FY | 3.48 Billion CNY | 13.63% |
| 2019 Q4 | 3.48 Billion CNY | 2.01% |
| 2019 Q3 | 3.41 Billion CNY | 4.82% |
| 2018 Q1 | 2.09 Billion CNY | 3.9% |
| 2018 FY | 3.06 Billion CNY | 52.32% |
| 2018 Q4 | 3.06 Billion CNY | 42.4% |
| 2018 Q3 | 2.15 Billion CNY | 5.48% |
| 2018 Q2 | 2.04 Billion CNY | -2.4% |
| 2017 FY | 2.01 Billion CNY | 6.33% |
| 2017 Q1 | 1.95 Billion CNY | 3.14% |
| 2017 Q2 | 2.04 Billion CNY | 4.57% |
| 2017 Q3 | 2.02 Billion CNY | -0.93% |
| 2017 Q4 | 2.01 Billion CNY | -0.48% |
| 2016 Q3 | 1.83 Billion CNY | 0.88% |
| 2016 Q1 | 1.87 Billion CNY | 27.16% |
| 2016 Q2 | 1.81 Billion CNY | -3.34% |
| 2016 Q4 | 1.89 Billion CNY | 3.31% |
| 2016 FY | 1.89 Billion CNY | 28.09% |
| 2015 Q1 | - CNY | -100.0% |
| 2015 FY | 1.47 Billion CNY | 28.5% |
| 2015 Q3 | 1.39 Billion CNY | 0.0% |
| 2015 Q4 | 1.47 Billion CNY | 5.67% |
| 2014 Q4 | 1.15 Billion CNY | 0.0% |
| 2014 FY | 1.15 Billion CNY | 14.03% |
| 2013 FY | 1 Billion CNY | 22.23% |
| 2012 FY | 825.37 Million CNY | 13.99% |
| 2011 FY | 724.07 Million CNY | 0.0% |